Search results
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 6 days agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 5 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 6 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance ...
11-year-old cancer survivor thriving after treatment supported by Alex's Lemonade Stand
CBS News· 9 hours agoThe family of a child fighting pediatric cancer was out of options when a doctor proposed a...
New blood cancer treatment saving lives, UVM officials say
WCAX-TV Vermont· 10 hours agoUniversity of Vermont Cancer Center officials say a promising treatment for blood cancer launched...
Postdoc to investigate molecular mechanisms in the field immune-rejuvenation for drug discovery -...
Nature· 2 days agoIn the compelling and unstoppable research in favor of cellular rejuvenation, Sentcell LTD is looking for PhD or Postdoc Researchers to investigate molecular mechanisms and innovative therapies ...
12 recent scientific breakthroughs
The Week via Yahoo News· 12 hours agoFood and Drug Administration (FDA) approved the first cellular therapy for aggressive forms of melanoma. The treatment, called Amtagvi, is "designed to...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Tehachapi News· 1 day ago"It is extremely encouraging to see this patient improving...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 16 hours agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell ...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 2 days agoMonday, the cell therapy-focused company announced that updated data from the ongoing Phase 1/2...
